Download PDF
CC BY-NC-ND 4.0 · Indian J Med Paediatr Oncol 2016; 37(03): 199-201
DOI: 10.4103/0971-5851.190363
CASE REPORT

Isolated humeral recurrence in endometrial carcinoma

Santosh Kumar Devdas
Department of Medical Oncology, M.S. Ramaiah Medical College, Bengaluru, Karnataka, India
,
Leela Digumarti
Department Gynaecological Oncology and Medical Oncology, Homi Bhabha Cancer Hospital and Research Centre, Aganampudi, Visakhapatnam, Andhra Pradesh, India
,
Raghunadharao Digumarti
Department Gynaecological Oncology and Medical Oncology, Homi Bhabha Cancer Hospital and Research Centre, Aganampudi, Visakhapatnam, Andhra Pradesh, India
,
Kunha Charan Patro
Department of Radiation Oncology, Mahatma Gandhi Cancer Hospital and Research Centre, MVP Colony, Visakhapatnam, Andhra Pradesh, India
,
Ramakoteswararao Nutakki
Chaitanya Medical Centre, Visakhapatnam, Andhra Pradesh, India
› Author Affiliations Financial support and sponsorship Nil.
› Further Information
  PDF Download Permissions and Reprints

Corrected by:

Erratum: Isolated humeral recurrence in endometrial carcinomaIndian J Med Paediatr Oncol 2016; 37(03): 320-320
DOI: 10.4103/0971-5851.195755

Abstract

Isolated skeletal metastasis in endometrial carcinoma at recurrence is very rare. We report a 52-year-old woman diagnosed to have FIGO Stage 1b, Grade 1 endometrioid adenocarcinoma, presenting with isolated distal humerus metastasis, 2 years after surgery and adjuvant radiotherapy for primary disease. Imaging, bone scintigraphy, and cytology confirmed the diagnosis of poorly differentiated metastatic adenocarcinoma. She was treated with local radiotherapy followed by six cycles of paclitaxel and carboplatin chemotherapy along with zoledronic acid, monthly. She is symptom-free after the treatment and at a first follow-up visit after 3 months.

Keywords

Bone metastasis - endometrial cancer - management - outcome


Publication History

Article published online:
12 July 2021

© 2016. Indian Society of Medical and Paediatric Oncology. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/.)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Boyle P, Levin B. World Cancer Report 2008. IARC Lyon, France: WHO LEON; 2008. p. 428.
  • 2 Creasman WT, Odicino F, Maisonneuve P, Quinn MA, Beller U, Benedet JL, et al. Carcinoma of the corpus uteri. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet 2006;95 Suppl 1:S105-43.
  • 3 Fujimoto T, Nanjyo H, Fukuda J, Nakamura A, Mizunuma H, Yaegashi N, et al.. Endometrial uterine cancer: Histopathological risk factors of local and distant recurrence. Gynecol Oncol 2009;112:342-7.
  • 4 Kehoe SM, Zivanovic O, Ferguson SE, Barakat RR, Soslow RA. Clinicopathologic features of bone metastases and outcomes in patients with primary endometrial cancer. Gynecol Oncol 2010;117:229-33.
  • 5 Uccella S, Morris JM, Bakkum-Gamez JN, Keeney GL, Podratz KC, Mariani A. Bone metastases in endometrial cancer: Report on 19 patients and review of the medical literature. Gynecol Oncol 2013;130:474-82.
  • 6 Kaya A, Olmezoglu A, Eren CS, Bayol U, Altay T, Karapinar L, et al. Solitary bone metastasis in the tibia as a presenting sign of endometrial adenocarcinoma: A case report and the review of the literature. Clin Exp Metastasis 2007;24:87-92.
  • 7 Mackiewicz-Wysocka M, Pankowska M, Wysocki PJ. Progress in the treatment of bone metastases in cancer patients. Expert Opin Investig Drugs 2012;21:785-95.
  • 8 Shigemitsu A, Furukawa N, Koike N, Kobayashi H. Endometrial cancer diagnosed by the presence of bone metastasis and treated with zoledronic acid: A case report and review of the literature. Case Rep Oncol 2010;3:471-6.
  • 9 Myriokefalitaki E, D'Costa D, Smith M, Ahmed AS. Primary bone metastasis as initial presentation of endometrial cancer (stage IVb). Arch Gynecol Obstet 2013;288:739-46.
  • 10 Yoon A, Choi CH, Kim TH, Choi JK, Park JY, Lee YY, et al. Bone metastasis in primary endometrial carcinoma: Features, outcomes, and predictors. Int J Gynecol Cancer 2014;24:107-12.
  • 11 Bryant CS, et al.. Sacral metastasis in endometrial cancer patient after treatment with sequential chemo-radiotherapy: A case report. Arch Oncol 2010;18:38-9.
  • 12 Abdul-Karim FW, Kida M, Wentz WB, Carter JR, Sorensen K, Macfee M, et al. Bone metastasis from gynecologic carcinomas: A clinicopathologic study. Gynecol Oncol 1990;39:108-14.
  • 13 Kurt M, Kilickap S, et al.. Isolated bone metastasis in early stage endometrial adenocarcinoma: A case report and review of the literature. Int J Haematol Oncol 2011;21:52-6.
  • 14 Solomayer EF, Gebauer G, Hirnle P, Janni W, Lück HJ, Becker S, et al. Influence of zoledronic acid on disseminated tumor cells in primary breast cancer patients. Ann Oncol 2012;23:2271-7.